tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Ross Osborn, 84 are a BUY (91.3%), 8 are a HOLD (8.7%).
Analyst Ross Osborn, currently employed at CANTOR FITZGERALD, carries an average stock price target met ratio of 29.58% that have a potential upside of 40.33% achieved within 114 days.
Ross Osborn’s has documented 179 price targets and ratings displayed on 18 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on MDXG, MiMedx Group at 27-Feb-2025.
Analyst best performing recommendations are on CVRX (CVRX).
The best stock recommendation documented was for CVRX (CVRX) at 10/23/2024. The price target of $14 was fulfilled within 7 days with a profit of $3.83 (37.66%) receiving and performance score of 53.8.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$2
$0.55 (37.93%)
$2.5
11 days ago
(20-Feb-2025)
6/8 (75%)
$0.23 (12.99%)
154
Hold
$1.5
$0.05 (3.45%)
$1.75
13 days ago
(18-Feb-2025)
3/6 (50%)
$-0.35 (-18.92%)
77
Buy
$2.5
$1.05 (72.41%)
$11
13 days ago
(18-Feb-2025)
0/2 (0%)
$0.65 (35.14%)
Buy
$6
$4.55 (313.79%)
3 months 20 days ago
(11-Nov-2024)
2/4 (50%)
$3.54 (143.90%)
26
Hold
$2
$0.55 (37.93%)
$12
3 months 20 days ago
(11-Nov-2024)
2/5 (40%)
$-0.46 (-18.70%)
56
Which stock is Ross Osborn is most bullish on?
Which stock is Ross Osborn is most reserved on?
What Year was the first public recommendation made by Ross Osborn?
